226 related articles for article (PubMed ID: 21537334)
1. DNMT3A mutations in myeloproliferative neoplasms.
Stegelmann F; Bullinger L; Schlenk RF; Paschka P; Griesshammer M; Blersch C; Kuhn S; Schauer S; Döhner H; Döhner K
Leukemia; 2011 Jul; 25(7):1217-9. PubMed ID: 21537334
[No Abstract] [Full Text] [Related]
2. Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.
Abdel-Wahab O; Pardanani A; Patel J; Wadleigh M; Lasho T; Heguy A; Beran M; Gilliland DG; Levine RL; Tefferi A
Leukemia; 2011 Jul; 25(7):1200-2. PubMed ID: 21455215
[No Abstract] [Full Text] [Related]
3. [Heterogeneity of leukemic cell phenotype. II. Variants of hetero- phenotype in relation to myeloid and megakaryocytic markers of leukemia cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Frend M; Dominis M
Gematol Transfuziol; 1990 Aug; 35(8):15-8. PubMed ID: 2253854
[No Abstract] [Full Text] [Related]
4. JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
Andrikovics H; Nahajevszky S; Koszarska M; Meggyesi N; Bors A; Halm G; Lueff S; Lovas N; Matrai Z; Csomor J; Rasonyi R; Egyed M; Varkonyi J; Mikala G; Sipos A; Kozma A; Adam E; Fekete S; Masszi T; Tordai A
Leukemia; 2010 Oct; 24(10):1809-13. PubMed ID: 20811399
[No Abstract] [Full Text] [Related]
5. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
6. Accelerated Phase of Myeloproliferative Neoplasms.
Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
Rotunno G; Guglielmelli P; Biamonte F; Rumi E; Cazzola M; Vannucchi AM
Ann Hematol; 2014 Mar; 93(3):523-4. PubMed ID: 23793880
[No Abstract] [Full Text] [Related]
8. Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.
Chen YY; Huang CE; Chou HJ; Tsai PS; Lu CH; Chen MF; Lee KD; Chen PT; Lung J; Chen CC
Ann Hematol; 2014 Aug; 93(8):1441-2. PubMed ID: 24337413
[No Abstract] [Full Text] [Related]
9. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
Marková J; Michková P; Burčková K; Březinová J; Michalová K; Dohnalová A; Maaloufová JS; Soukup P; Vítek A; Cetkovský P; Schwarz J
Eur J Haematol; 2012 Feb; 88(2):128-35. PubMed ID: 21967546
[TBL] [Abstract][Full Text] [Related]
10. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.
Schnittger S; Bacher U; Haferlach C; Alpermann T; Dicker F; Sundermann J; Kern W; Haferlach T
Leukemia; 2011 Apr; 25(4):615-21. PubMed ID: 21233837
[TBL] [Abstract][Full Text] [Related]
11. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
Iurlo A; Cattaneo D; Gianelli U
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.
Han X; Medeiros LJ; Abruzzo LV; Jones D; Lin P
Am J Clin Pathol; 2006 Jan; 125(1):49-56. PubMed ID: 16482991
[TBL] [Abstract][Full Text] [Related]
13. The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations.
Tiacci E; Spanhol-Rosseto A; Martelli MP; Pasqualucci L; Quentmeier H; Grossmann V; Drexler HG; Falini B
Leukemia; 2012 Mar; 26(3):554-7. PubMed ID: 21904384
[No Abstract] [Full Text] [Related]
14. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
Tefferi A
Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
[No Abstract] [Full Text] [Related]
15. Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?
Tefferi A
Leukemia; 2011 Jul; 25(7):1059-63. PubMed ID: 21750560
[No Abstract] [Full Text] [Related]
16. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
17. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.
Mayeur-Rousse C; Sorel N; Voldoire M; Canioni D; Brizard F; Randriamalala E; Turhan AG; Chomel JC
Leuk Res; 2012 Mar; 36(3):377-81. PubMed ID: 22030335
[No Abstract] [Full Text] [Related]
18. Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model.
Hollink IH; Feng Q; Danen-van Oorschot AA; Arentsen-Peters ST; Verboon LJ; Zhang P; de Haas V; Reinhardt D; Creutzig U; Trka J; Pieters R; van den Heuvel-Eibrink MM; Wang J; Zwaan CM
Leukemia; 2012 Feb; 26(2):371-3. PubMed ID: 21836609
[No Abstract] [Full Text] [Related]
19. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
[TBL] [Abstract][Full Text] [Related]
20. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling.
Flach J; Dicker F; Schnittger S; Schindela S; Kohlmann A; Haferlach T; Kern W; Haferlach C
Leukemia; 2011 Apr; 25(4):713-8. PubMed ID: 21233836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
